全球抗体生产市场规模、份额、趋势和成长分析报告（2026-2034年）

预计抗体生产市场将从 2025 年的 259.8 亿美元成长到 2034 年的 533 亿美元，2026 年至 2034 年的复合年增长率为 8.31%。

全球抗体生产市场正经历显着成长，这主要得益于肿瘤、自体免疫疾病和感染疾病领域单株抗体开发平臺的扩张。监管核准的增加和生物相似药研发的进展正在加速生产需求。生物製药设施的扩建以及外包给合约研发生产机构（CDMO）的增加，正在支持生产规模的扩大并增强全球供给能力。

关键成长要素包括细胞株设计技术、製程整合技术以及一次性生物反应器系统的进步，这些进步能够提高生产产量并降低成本。对基于抗体的诊断试剂和科研试剂的需求成长也是推动收入成长的主要动力。此外，对生物相似药和双特异性抗体等复杂抗体形式的投资增加，正在加速产业内的创新和竞争。

展望未来，随着抗体药物复合体（ADC）和新一代生物製药的商业化，市场预计将持续扩张。连续生产、模组化设施数位化品管系统将简化作业流程并缩短产品上市时间。新兴经济体预计将在扩大产能方面发挥重要作用，而监管协调将有助于更广泛的全球分销。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章 全球抗体生产市场：以抗体类型划分

• 市场分析、洞察与预测
• 单株抗体
• 多株抗体
• 其他抗体类型

第五章 全球抗体生产市场：依製程划分

• 市场分析、洞察与预测
• 上游工程
• 下游工艺
• 过滤

第六章 全球抗体生产市场：依最终用户划分

• 市场分析、洞察与预测
• 製药和生物技术公司
• 研究所
• 其他最终用户

第七章 全球抗体生产市场：依地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第八章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第九章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Danaher Corporation
  • Merck KGaA
  • Sartorius
  • Thermo Fisher Scientific Inc
  • Eppendorf AG
  • INTEGRA Biosciences AG
  • Genetix Biotech Asia Pvt Ltd
  • Solaris Biotech
  • Grifols
  • F. Hoffmann-La Roche AG
  • FiberCell Systems Inc

The Antibody Production Market size is expected to reach USD 53.30 Billion in 2034 from USD 25.98 Billion (2025) growing at a CAGR of 8.31% during 2026-2034.

The Global Antibody Production market is experiencing significant growth due to the expanding pipeline of monoclonal antibodies across oncology, autoimmune diseases, and infectious disorders. Increasing regulatory approvals and biosimilar development have intensified manufacturing demand. Expansion of biologics facilities and greater outsourcing to contract development and manufacturing organizations (CDMOs) are supporting production scale-up and enhancing global supply capabilities.

Major growth drivers include advancements in cell line engineering, process intensification technologies, and single-use bioreactor systems that improve yield and reduce production costs. Rising demand for antibody-based diagnostics and research reagents further strengthens revenue generation. Additionally, increased investment in biosimilars and complex antibody formats, such as bispecific antibodies, is accelerating innovation and competitive activity within the sector.

Looking ahead, the market is poised for sustained expansion with the commercialization of antibody-drug conjugates and next-generation biologics. Continuous manufacturing, modular facilities, and digitalized quality control systems will streamline operations and reduce time-to-market. Emerging economies are expected to play a critical role in capacity expansion, while regulatory harmonization will facilitate broader global distribution.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Antibody Type

• Monoclonal Antibodies
• Polyclonal Antibodies
• Other Antibody Types

By Process

• Upstream Processing
• Downstream Processing
• Filtration

By End-user

• Pharmaceutical and Biotechnology Companies
• Research Laboratories
• Other End-users

COMPANIES PROFILED

• Danaher Corporation, Merck KGaA, Sartorius, Thermo Fisher Scientific Inc, Eppendorf AG, INTEGRA Biosciences AG, Genetix Biotech Asia Pvt Ltd, Solaris Biotech, Grifols, F HoffmannLa Roche AG, FiberCell Systems Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL ANTIBODY PRODUCTION MARKET: BY ANTIBODY TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Antibody Type
• 4.2. Monoclonal Antibodies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Polyclonal Antibodies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Other Antibody Types Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL ANTIBODY PRODUCTION MARKET: BY PROCESS 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Process
• 5.2. Upstream Processing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Downstream Processing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Filtration Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL ANTIBODY PRODUCTION MARKET: BY END-USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-user
• 6.2. Pharmaceutical and Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Research Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Other End-users Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL ANTIBODY PRODUCTION MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Antibody Type
  • 7.2.2 By Process
  • 7.2.3 By End-user
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Antibody Type
  • 7.3.2 By Process
  • 7.3.3 By End-user
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Antibody Type
  • 7.4.2 By Process
  • 7.4.3 By End-user
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Antibody Type
  • 7.5.2 By Process
  • 7.5.3 By End-user
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Antibody Type
  • 7.6.2 By Process
  • 7.6.3 By End-user
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL ANTIBODY PRODUCTION INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Danaher Corporation
  • 9.2.2 Merck KGaA
  • 9.2.3 Sartorius
  • 9.2.4 Thermo Fisher Scientific Inc
  • 9.2.5 Eppendorf AG
  • 9.2.6 INTEGRA Biosciences AG
  • 9.2.7 Genetix Biotech Asia Pvt Ltd
  • 9.2.8 Solaris Biotech
  • 9.2.9 Grifols
  • 9.2.10 F. Hoffmann-La Roche AG
  • 9.2.11 FiberCell Systems Inc